You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

477 Results
Document
Nov 2022
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Neoadjuvant
Funding:
New Drug Funding Program
    Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
DOXOrubicin,
cyclophosphamide
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Sep 2023
Document
Apr 2023
.
Les fournisseurs de soins de santé trouveront ici des renseignements et des ressources de pratiques exemplaires au sujet des types de dépistage...
Document
Jun 2023
Document
Aug 2023
Document
Sep 2023
Document
Sep 2023
Guidelines and Advice
Status: Current
ID: GL-END-C50-35
Aug 2023
Statistical Reports
Jan 2024
Guidelines and Advice
Status: Current
ID: C50-CIDAP-1
Mar 2024

Pages